# MBX Biosciences, Inc.: Form SCHEDULE 13D/A, filed Sep 30, 2025

- Company: [MBX Biosciences, Inc.](/companies/mbx.md) (CIK 1776111)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-30
- Accepted by EDGAR: Sep 30, 2025, 17:01 ET
- Period: not reported
- Accession: 0001863769-25-000010
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1776111/000186376925000010/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776111/000186376925000010/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776111/000186376925000010/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001863769-25-000010. Last ingested by Listed: Nov 12, 2026, 18:07 ET. No prices; not investment advice.
